Evidence of oxidative stress in very long chain fatty acid - Treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins

Neuroscience

Volumn 213, Issue , 2012, Pages 1-18

  Baarine, M ^a   Andreoletti P ^a   Athias, A ^b   Nury, T ^a   Zarrouk, A ^a,c   Ragot, K ^a   Vejux, A ^a   Riedinger, J M ^d   Kattan, Z ^a   Bessede, G ^b   Trompier, D ^a   Savary, S ^a   Cherkaoui Malki, M ^a   Lizard, G ^a  

^a Faculté des Sciences Gabriel   (France)

^b HÔPITAL DU BOCAGE   (France)

^c UNIVERSITY OF MONASTIR   (Tunisia)

^d Centre de Lutte Contre le Cancer GF Leclerc   (France)

Author keywords

158N murine oligodendrocytes; 4 Hne; Abcd1; Acox1; Amn; Cns; Ct; Dhr123; Dmem; Edta; Ffa; Gc Ms; Gsh; Hodes; Lcfa; Mcb; No; Oxidative stress; P Nald; Rns; Ros; Scr; Sod; Vlcfa; X Ald

Indexed keywords

4 HYDROXYNONENAL; ABC TRANSPORTER; ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; ATP BINDING CASSETTE TRANSPORTER D 1; CATALASE; FATTY ACID; GLUTATHIONE; HYDROGEN PEROXIDE; HYDROXYOCTADECADIENOIC ACID; NITRIC OXIDE; PHOSPHOLIPID; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SILENCING; LIPID PEROXIDATION; LIPID STORAGE; MOUSE; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PEROXISOME; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; RNA INTERFERENCE;

ACYL-COA OXIDASE; ADRENOLEUKODYSTROPHY; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CELLS, CULTURED; FATTY ACIDS; FLOW CYTOMETRY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE KNOCKDOWN TECHNIQUES; MICE; OLIGODENDROGLIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXISOMES; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSFECTION;

EID: 84861658605     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.03.058     Document Type: Article

References (90)

1. Arnauld S., Fidaleo M., Clémencet M.C., Chevillard G., Athias A., Gresti J., Wanders R.J., Latruffe N., Nicolas-Francès V., Mandard S. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643. Biochimie 2009, 91:1376-1386.
2. Awasthi Y.C., Sharma R., Cheng J.Z., Yang Y., Sharma A., Singhal S.S., Awasthi S. Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol Aspects Med 2003, 24:219-230.
3. Baarine M., Ragot K., Genin E.C., El Hajj H., Trompier D., Andreoletti P., Ghandour M.S., Menetrier F., Cherkaoui-Malki M., Savary S., Lizard G. Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): potential models for the study of peroxisomal disorders associated with dysmyelination processes. J Neurochem 2009, 111:119-131.
4. Baarine M., Ragot K., Athias A., Nury T., Kattan Z., Genin E.C., Andreoletti P., Ménétrier F., Riedinger J.M., Bardou M., Lizard G. Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-α on oligodendrocytes and astrocytes. Neurotoxicology 2012, 32:212-228.
5. Baes M., Aubourg P. Peroxisomes, myelination, and axonal integrity in the CNS. Neuroscientist 2009, 15:367-379.
6. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001, 81:871-927.
7. Berger J., Gartner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta 2006, 1763:1721-1732.
8. Berger J., Pujol A., Aubourg P., Forss-Petter S. Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy. Brain Pathol 2010, 20:845-856.
9. Bottelbergs A., Verheijden S., Hulshagen L., Gutmann D.H., Goebbels S., Nave K.A., Kassmann C., Baes M. Axonal integrity in the absence of functional peroxisomes from projection neurons and astrocytes. GLIA 2010, 58:1532-1543.
10. Brites P., Waterham H.R., Wanders R.J. Functions and biosynthesis of plasmalogens in health and diseases. Biochim Biophys Acta 2004, 1636:219-231.
11. Catala A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids 2009, 157:1-11.
12. Carrozzo R., Bellini C., Lucioli S., Deodato F., Cassandrini D., Cassanello M., Caruso U., Rizzo C., Rizza T., Napolitano M.L., Wanders R.J., Jakobs C., Bruno C., Santorelli F.M., Dionisi-Vici C., Bonioli E. Peroxisomal acyl-CoA-oxidase deficiency: two new cases. Am J Med Genet A 2008, 146A:1676-1681.
13. Chaudière J., Ferrari-Iliou R. Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol 1999, 37:949-962.
14. Cimini A., Bernardo A., Cifone G., Di Muzio L., Di Loreto S. TNFα downregulates PPARδ expression in oligodendrocytes progenitor cells: implication for demyelinating diseases. GLIA 2003, 41:3-14.
15. de Medina P., Paillasse M.R., Payré B., Silvente-Poirot S., Poirot M. Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases. J Med Chem 2009, 52:7765-7777.
16. Deon M., Sitta A., Barschak A.G., Coelho D.M., Pigatto M., Schmitt G.O., Jardim L.B., Giugliani R., Wajner M., Vargas C.R. Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy. Int J Dev Neurosci 2007, 25:441-444.
17. Deon M., Sitta A., Barschak A.G., Coelho D.M., Terroso T., Schmitt G.O., Wanderley H.Y., Jardim L.B., Giugliani R., Wajner M., Vargas C.R. Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy. J Neurol Sci 2008, 266:79-83.
18. Depreter M., Espeel M., Roels F. Human peroxisomal disorders. Microsc Res Tech 2003, 61:203-223.
19. Di Biase A., Di Benedetto R., Fiorentini C., Travaglione S., Salvati S., Attorri L., Pietraforte D. Free radical release in C6 glial cells enriched in hexacosanoic acid: implication for X-linked adrenoleukodystrophy pathogenesis. Neurochem Int 2004, 44:215-221.
20. Dobashi K., Pahan K., Chahal A., Singh I. Modulation of endogenous antioxidant enzymes by nitric oxide in rat C6 glial cells. J Neurochem 1997, 68:1896-1903.
21. Eichler F.S., Ren J.Q., Cossoy M., Rietsch A.M., Nagpal S., Moser A.B., Frosch M.P., Ransohoff R.M. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?. Ann Neurol 2008, 63:729-742.
22. Engels F., Kessels G.C., Schreurs A.J., Nijkamp F.P. Production of arachidonic acid and linoleic acid metabolites by human bronchoalveolar lavage cells. Prostaglandins 1991, 42:441-450.
23. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11:81-128.
24. Feigenbaum V., Gélot A., Casanova P., Daumas-Duport C., Aubourg P., Dubois-Dalcq M. Apoptosis in the central nervous system of cerebral adrenoleukodystrophy patients. Neurobiol Dis 2000, 7(6 Pt B):600-612.
25. Ferdinandusse S., Denis S., Hogenhout E.M., Koster J., van Roermund C.W.T., Ljlst L., Moser A.B., Wanders R.J.A., Waterham H.R. Clinical, biochemical, and mutational spectrum of peroxisomal Acyl-CoenzymeA oxidase deficiency. Hum Mut 2007, 28:904-912.
26. Ferrer I., Aubourg P., Pujol A. General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol 2010, 20:817-830.
27. Feutz A.C., Pham-Dinh D., Allinquant B., Miehe M., Ghandour S. An immortalized jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway. GLIA 2001, 34:241-252.
28. Folch J., Lees M., Sloanes Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
29. Forman H.J., Zhang H., Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med 2009, 30:1-12.
30. Fourcade S., López-Erauskin J., Galino J., Duval C., Naudi A., Jove M., Kemp S., Villarroya F., Ferrer I., Pamplona R., Portero-Otin M., Pujol A. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet 2008, 17:1762-1773.
31. Fourcade S., Ruiz M., Guilera C., Hahnen E., Brichta L., Naudi A., Portero-Otín M., Dacremont G., Cartier N., Wanders R., Kemp S., Mandel J.L., Wirth B., Pamplona R., Aubourg P., Pujol A. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy. Hum Mol Genet 2010, 19:2005-2014.
32. Fournier B., Saudubray J.M., Benichou B., Lyonnet S., Munnich A., Clevers H., Poll-The B.T. Large depletion of the peroxisomal acyl-CoA oxidase gene in pseudonatal adrenoleukodystrophy. J Clin Invest 1994, 94:526-531.
33. Fukai T., Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 2011, 15:1583-1606.
34. Galino J., Ruiz M., Fourcade S., Schlüter A., López-Erauskin J., Guilera C., Jove M., Naudi A., García-Arumí E., Andreu A.L., Starkov A.A., Pamplona R., Ferrer I., Portero-Otin M., Pujol A. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal 2011, 15:2095-2107.
35. Genin E.C., Geillon F., Gondcaille C., Athias A., Gambert P., Trompier D., Savary S. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2). J Biol Chem 2011, 286:8075-8084.
36. Gilg A.G., Singh A.K., Singh I. Inducible nitric oxide synthase in the central nervous system of patients with X-adrenoleukodystrophy. J Neuropathol Exp Neurol 2000, 59:1063-1069.
37. Grimsrud P.A., Xie H., Griffin T.J., Bernlohr D.A. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 2008, 283:21837-21841.
38. Haugland, R.P. (2010). Molecular probes handbook, a guide to fluorescent probes and labeling technologies. 11th Edition, Molecular Probes/Invitrogen/Life Technologies. Editors: Johnson I and Spence MTZ.
39. Harauz G., Ishiyama N., Hill C., Bates I.R., Libich D.S., Farès C. Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron 2004, 35:503-542.
40. Hedley D.W., Chow S. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 1994, 15:349-358.
41. Hein S., Schönfeld P., Kahlert S., Reiser G. Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet 2008, 17:1750-1761.
42. Hubbard W.C., Moser A.B., Liu A.C., Jones R.O., Steinberg S.J., Lorey F., Panny S.R., Vogt R.F., Macaya D., Turgeon C.T., Tortorelli S., Raymond G.V. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. Mol Genet Metab 2009, 97:212-220.
43. Kahn E., Baarine M., Dauphin A., Ragot K., Tissot N., Seguin A., Ménétrier F., Kattan Z., Bachelet C.M., Frouin F., Lizard G. Impact of 7-ketocholesterol and very long chain fatty acids on oligodendrocyte lipid membrane organization: evaluation via LAURDAN and FAMIS spectral image analysis. Cytometry A 2011, 79:293-305.
44. Kaluzny M.A., Duncan L.A., Merritt M.V., Epps D.E. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J. Lipid Res 1985, 26:135-140.
45. Kassmann C., Lappe-Siefke C., Baes M., Brügger B., Mildner A., Werner H.K., Natt O., Michaelis T., Prinz M., Frahm J., Nave K.A. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 2007, 39:969-976.
46. Kawajiri H., Hsi L.C., Kamitani H., Ikawa H., Geller M., Ward T., Eling T.E., Glasgow W.C. Arachidonic and linoleic acid metabolism in mouse intestinal tissue: evidence for novel lipoxygenase activity. Arch Biochem Biophys 2002, 398:51-60.
47. Kemp S., Pujol A., Waterham H.R., van Geel B.M., Boehm C.D., Raymond G.V., Cutting G.R., Wanders R.J., Moser H.W. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat 2001, 18:499-515.
48. Kemp S., Wanders R.J. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab 2007, 90:268-276.
49. Kemp S., Wanders R. Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol 2010, 20:831-837.
50. Khan M., Pahan K., Singh A.K., Singh I. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystophy. J Neurochem 1998, 71:78-87.
51. Khan M., Singh J., Gilg A.G., Uto T., Singh I. Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy. J Lipid Res 2010, 51:1685-1695.
52. Kishimoto Y., Moser H.W., Kawamura N., Platt M., Pallante S.L., Fenselau C. Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin. Biochem Biophys Res Commun 1980, 96:69-76.
53. López-Erauskin J., Fourcade S., Galino J., Ruiz M., Schlüter A., Naudi A., Jove M., Portero-Otin M., Pamplona R., Ferrer I., Pujol A. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol 2011, 70:84-92.
54. Martínez A., Portero-Otin M., Pamplona R., Ferrer I. Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 2010, 20:281-297.
55. McGuinness M.C., Griffin D.E., Raymond G.V., Washington C.A., Moser H.W., Smith K.D. Tumor necrosis factor-alpha and X-linked adrenoleukodystrophy. J Neuroimmunol 1995, 61:161-169.
56. McQuade L.E., Lippard S.J. Fluorescent probes to investigate nitric oxide and other reactive nitrogen species in biology (truncated form: fluorescent probes of reactive nitrogen species). Curr Opin Chem Biol 2010, 14:43-49.
57. Meister A., Anderson M.E. Glutathione. Annu Rev Biochem 1983, 52:711-760.
58. Mosser J., Douar A.M., Sarde C.O., Kioschis P., Feil R., Moser H., Poustka A.M., Mandel J.L., Aubourg P. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993, 361:726-730.
59. Nam D.T., Arseneault M., Murthy V., Ramassamy C. Potential role of acrolein in neurodegeneration and in Alzheimer's disease. Curr Mol Pharmacol 2010, 3:66-78.
60. Oaxaca-Castillo D., Andreoletti P., Vluggens A., Yu S., van Veldhoven P., Reddy J.K., Cherkaoui-Malki M. Functional expression and characterization of recombinant human liver acyl-CoA oxidase isoforms 1a and 1b. Biochim Biophys Res Commun 2007, 360:314-319.
61. Ofman R., Dijkstra I.M., van Roermund C.W., Burger N., Turkenburg M., van Cruchten A., van Engen C.E., Wanders R.J., Kemp S. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol Med 2010, 2:90-97.
62. Paintlia A.S., Gilg A.G., Khan M., Singh A.K., Barbosa E., Singh I. Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis 2003, 14:425-439.
63. Pujol A., Hindelang C., Callizot N., Bartsch U., Schachner M., Mandel J.L. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 2002, 11:499-505.
64. Pujol A., Ferrer I., Camps C., Metzger E., Hindelang C., Callizot N., Ruiz M., Pàmpols T., Giròs M., Mandel J.L. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet 2004, 13:2997-3006.
65. Reed D.J. Glutathione: toxicological implication. Annu Rev Pharmacol 1990, 30:603-631.
66. Robinson K.M., Janes M.S., Beckman J.S. The selective detection of mitochondrial superoxide by live cell imaging. Nat Protoc 2008, 3:941-947.
67. Rothe G., Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2',7'-dichlorofluorescin. J Leukoc Biol 1990, 47:440-448.
68. Rothe G., Valet G. Flow cytometric assays of oxidative burst activity in phagocytes. Methods Enzymol 1994, 233:539-548.
69. Rothstein J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009, 65(Suppl. 1):S3-S9.
70. Saito Y., Yoshida Y., Niki E. Cholesterol is more susceptible to oxidation than linoleates in cultured cells under oxidative stress induced by selenium deficiency and free radicals. FEBS Lett 2007, 581:4349-4354.
71. Schlüter A., Espinosa L., Fourcade S., Galino J., López E., Ilieva E., Morató L., Asheuer M., Cook T., McLaren A., Reid J., Kelly F., Bates S., Aubourg P., Galea E., Pujol A. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy. Hum Mol Genet 2012, 21:1062-1077.
72. Schrader M., Fahimi D. Mammalian peroxisomes and reactive oxygen species. Histochem Cell Biol 2004, 122:383-393.
73. Schrader M., Fahimi H.D. The peroxisome: still a mysterious organelle. Histochem Cell Biol 2008, 129:421-440.
74. Seet R.C., Lee C.Y., Lim E.C., Tan J.J., Quek A.M., Chong W.L., Looi W.F., Huang S.H., Wang H., Chan Y.H., Halliwell B. Oxidative damage in Parkinson disease: measurement using accurate biomarker. Free Radic Biol Med 2010, 48:560-566.
75. Singh I., Kishimoto Y. Effect of cyclodextrins on the solubilization of lignoceric acid, ceramide, and cerebroside, and on the enzymatic reactions involving these compounds. J Lipid Res 1983, 24:662-665.
76. Singh J., Khan M., Singh I. Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy. J Lipid Res 2009, 50:135-147.
77. Singh I., Pujol A. Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol 2010, 20:838-844.
78. Suzuki Y., Iai M., Kamei A., Tanabe Y., Chida S., Yamaguchi S., Zhang Z., Takemoto Y., Shimozawa N., Kondo N. Peroxisomal acyl CoA oxidase deficiency. J Pediatr 2002, 140:128-130.
79. Takemoto Y., Suzuki Y., Horibe R., Shimozawa N., Wanders R.J., Kondo N. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders. Brain Dev 2003, 25:481-487.
80. Tsuji S., Sano T., Ariga T., Miyatake T. Increased synthesis of hexacosanoic acid (C26:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). J Biochem (Tokyo) 1981, 90:1233-1236.
81. Uto T., Contreras M.A., Gilg A.G., Singh I. Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts. Dev Neurosci 2008, 30:410-418.
82. Valianpour F., Selhorst J.J., van Lint L.E., van Gennip A.H., Wanders R.J., Kemp S. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Mol Genet Metab 2003, 79:189-196.
83. Vargas C.R., Wajner M., Sirtori L.R., Goulart L., Chiochetta M., Coelho D., Latini A., Llesuy S., Bello-Klein A., Giugliani R., Deon M., Mello C.F. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta 2004, 1688:26-32.
84. Vejux A., Lizard G. Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med 2009, 30:153-170.
85. Vluggens A., Andreoletti P., Viswakarma N., Jia Y., Matsumoto K., Kulik W., Khan M., Huang J., Guo D., Yu S., Sarkar J., Singh I., Rao M.S., Wanders R.J., Reddy J.K., Cherkaoui-Malki M. Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform. Lab Invest 2010, 90:696-708.
86. Wanders R.J., Waterham H.R. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 2006, 75:295-332.
87. Warner H.R. Superoxide dismutase, aging, and degenerative disease. Free Radic Biol Med 1994, 17:249-258.
88. Watkins P.A., Chen W.W., Harris C.J., Hoefler G., Hoefler S., Blake D.C., Balfe A., Kelley R.I., Moser A.B., Beard M.E., Moser H.W. Peroxisomal bifunctional enzyme deficiency. J Clin Invest 1989, 83:771-777.
89. Yoshida Y., Kodai S., Takemura S., Minamiyama Y., Niki E. Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples. Anal Biochem 2008, 379:105-115.
90. Zimmerman M.C., Oberley L.W., Flanagan S.W. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels. J Neurochem 2007, 102:609-618.